NCT02680457View on ClinicalTrials.gov

Effect of Insulin Degludec Versus Insulin Glargine on Glycemic Variability in Patients With Type 2 Diabetes Mellitus

PHASE4CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

November 30, 2013

Primary Completion Date

July 31, 2015

Study Completion Date

November 30, 2016

Conditions
Type 2 Diabetes Mellitus
Interventions
DRUG

Insulin Degludec

Insulin Degludec 10 IU SC every 24 hours for 6 days

DRUG

Insulin Glargine

Insulin Glargine 10 IU SC every 24 hours for 6 days

Trial Locations (1)

44340

Instituto de Terapeútica Experimental y Clínica. Centro Universitario de Ciencias de la Salud. Universidad de Guadalajara, Guadalajara

All Listed Sponsors
lead

University of Guadalajara

OTHER

NCT02680457 - Effect of Insulin Degludec Versus Insulin Glargine on Glycemic Variability in Patients With Type 2 Diabetes Mellitus | Biotech Hunter | Biotech Hunter